Evidence map›Paper›PMID 28653240›Full record

ArticleMolecular imaging and biology2018

ImmunoPET Imaging of α

Jason B White, Lina Y Hu, David L Boucher, Julie L Sutcliffe

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Preclinical Evaluation of an Integrin αBioconjugate chemistry · 2025
    Article
  3. Evaluation of [Molecular imaging and biology · 2025
    Article
  4. Article
  5. Review
  6. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  7. Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment.International journal of molecular sciences · 2022
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. PET radiometals for antibody labeling.Journal of labelled compounds & radiopharmaceuticals · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jason B WhiteDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, USA.
Lina Y HuDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, USA.
David L BoucherDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, USA.
Julie L SutcliffeDepartment of Biomedical Engineering, University of California, Davis, Davis, CA, USA. jlsutcliffe@ucdavis.edu.

Funding

U.S. Department of Energy DE-SC0002061 and DE-SC0008385
6 · The paper itself

Abstract

purposeIncreased expression of the α PROCEDURES: Small-animal positron emission tomography (PET) imaging, quantitative ROI analysis, and ex vivo biodistribution were conducted to ascertain tumor uptake and organ distribution of the [

resultsPET imaging of the [

conclusionsSmall-animal PET imaging was successful in visualizing α

Indexed as

Positron-Emission TomographyProtein EngineeringAnimalsAntigens, NeoplasmCopper RadioisotopesEnzyme-Linked Immunosorbent AssayFemaleImmunoglobulin FragmentsIntegrinsMice, NudeOrgan SpecificityRadiopharmaceuticalsTissue DistributionTomography, X-Ray ComputedAntigens, NeoplasmCopper-64Copper RadioisotopesImmunoglobulin Fragmentsintegrin alphavbeta6IntegrinsRadiopharmaceuticalsAlpha v beta 6 integrinAntibody fragmentsCopper-64Cys-diabodyImmunoPETMolecular imagingSite-specific conjugation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.